Navigation Links
Beauty for Life: The Future of Cosmetic Medicine
Date:5/2/2008

SAN DIEGO, May 2 /PRNewswire-USNewswire/ -- With Botox available at the mall and laser-hair removal offered at the neighborhood nail salon how can patients make sure they are getting safe and effective procedures? The future of Cosmetic Medicine will be discussed by leading experts at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS) being held at the San Diego Convention Center May 2-6, 2008. "Cosmetic Medicine: Embracing the Future" will be moderated by Robert Singer, MD, and will include Renato Saltz, MD, Richard D'Amico, MD, Roxanne Guy, MD (Mentor Corporation, Allergan and ColBar LifeScience), and Rod Rohrich, MD.

According to recent ASAPS data, nearly 11.7 million cosmetic procedures were performed in the United States in 2007 - an increase of 457 percent in the last ten years. The expansion of aesthetic surgery to include non-surgical, and even medical, treatments is occurring rapidly, and while plastic surgeons are uniquely capable of providing the whole spectrum of cosmetic medicine, other medical specialties are also attempting to provide this service.

"There has been a steady increase in the number of procedures, both surgical and less invasive, over the past several years," said Dr. Singer, a plastic surgeon in La Jolla, CA and a past-president of the Aesthetic Society. "What is the future of cosmetic medicine and what will the role of less invasive procedures be? We need to examine the reality and the limitations of these noninvasive procedures and those who are providing them in order to be better equipped to educate the public, limit hype and ensure the safety of patients."

The panelists all hold positions at the highest levels of leadership in the plastic surgical societies and have tremendous experience and insight into this important issue. They will discuss emerging trends in the practice of plastic surgery and the business of cosmetic medicine as a whole: To what extent can plastic
'/>"/>

SOURCE American Society for Aesthetic Plastic Surgery
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Womens Beauty, Mens Wealth Key to Romance: Study
2. Allure Magazine Names Remergent(R) DNA Repair Formula Best of Beauty
3. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
4. AMDL Launches Expanded Distribution With 4th Round of Agreements Valued at $6.79 Million Annually for New Health & Beauty Product Line
5. Leading neuroscientist seeks beauty, love and happiness
6. Kline Analysts Say Clinique-Allergan Deal Sets Beauty Industry Precedent in Channel Diversification
7. Better Nutrition Announces Best Of Beauty Awards Winners Showcasing the Best Natural Beauty Products of 2008
8. The beauty bias: Can people love the one they are compatible with?
9. Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications
10. When It Comes to a Mate, Beauty Cant Be Beat
11. 5W Public Relations Hosts Exclusive Beauty & Wellness Industry Event

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ire-USNewswire/ -- Considered a highly risky and c...solid organ transplantation is now a life-saving m...n and women who gathered at the Winspear Opera Hou...m medical centers around the world to celebrate th...nstitute (BRTI), one of the pioneers of solid orga...
(Date:11/27/2009)...ov. 27 Shamir Optical In...ng provider of innovative products and technology ...t its board of directors had declared a dividend d...on (approximately NIS 37.62 million based on the N... or approximately US$ 0.609 (approximately NIS 2.3...
(Date:11/27/2009)... Nov. 27 Allrecipes.com , the w...ving traffic numbers, with more than 2.8 million v...lear picture of what was served on the biggest foo...al in 2009 weighed in at 2,225 calories per servin...cording to the Allrecipes site, Sweet Potato Pie ...
(Date:11/27/2009)...interactive anatomy education apps from Modality a... sciences learning opportunities for iPhone and iP...cus) November 27, 2009 -- Modality, Inc. and Lip...f Wolters Kluwer Health, today announced the avail... App Store. Clemente’s Anatomy, Rohen’...
(Date:11/26/2009)...thiomolybdate (TM) has been shown in studies to be...isease caused by an overload of copper, and certai...tle, however, is known about how the drug works at...western University researchers now has provided an...of TM bound to copper-loaded metallochaperones. Th...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...H, Minn., April 29 ev3 Inc. (Nasdaq:,EVVV) today ...ef executive,officer, is scheduled to present at t...uesday, May 13, 2008 at 4:00 p.m. PT (7:00 p.m. ET...t, go to the investors, section of the ev3 Web sit...
...tate contracts EDS interChange System to manage na...program, New IT solution will administer payments ...th records, help state identify health trends and ...ents, has been awarded a,seven-year, $391 million ...
...rphy Appointed as New Senior Vice President of Con... Pharsight,Corporation (Nasdaq: PHST ), a leadin...regulatory services for optimizing clinical drug,d...es. In this role, Dr. Murphy will lead the Company...
...LE, Tenn., April 29 With an 89% initial success,r...ggressive cancers, a,Nashville-based treatment is ...cording to NeoPlas Innovation Director of Research...en effective,for malignant melanoma, as well as pa...
...rence Call to Occur on Wednesday, April 30 at 2 p....on, Inc.,(Nasdaq: VRML ), a molecular diagnostics... address the need for improved detection of periph...nce will take place on Wednesday, April 30 at 2 p....
...TOWNSHIP, Michigan, April 28 Nearly ten years,aft... three years after FDA,approval, LASIK surgery is ...ered complications or experienced poor outcomes., ...n, to pain, to severe activity-limiting visual hal...
Other Medicine News:Health News:EDS Returns to Georgia With $391 Million Medicaid Win 2Health News:EDS Returns to Georgia With $391 Million Medicaid Win 3Health News:Pharsight Strengthens Senior Management Team 2Health News:Pharsight Strengthens Senior Management Team 3Health News:New Treatment Offers Hope for Beating Aggressive Cancers 2Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 2Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 3Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 4Health News:FDA Examines LASIK Surgery Complications 2
(Date:11/25/2009)...RNewswire-FirstCall/ -- ERT (Nasdaq: ERES ), anno...any,s President and CEO, and Keith Schneck, the Co...duled to present at the 21st Annual Piper Jaffray ...1, 2009 in New York City, New York. ,, Interest... the Company,s corporate website at http://www.er...
(Date:11/25/2009)...ire/ -- BioTrends Research Group, Inc. released Wa...rt, the first in a multi-phase syndicated market r...tho-Biotech,s Stelara, from product launch through...of the report provides quantitative information fr...ation from a subset of 20. The reports assess tri...
(Date:11/25/2009)... 25 For many of the mill... 27 million living with untreated hearing loss , ...logist Cindy Beyer. ,, Dr. Beyer, senior vice p...s largest hearing care and hearing aids companie..., frustration, and social isolation, "which can ea...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3MAQUET Cardiovascular Awarded New Contract by Novation 51197 1MAQUET Cardiovascular Awarded New Contract by Novation 51197 2Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration 12954 1Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration 12954 2IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 1IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 2
...ADELPHIA, May 22 Shire plc (LSE: SHP, Nasdaq: ...ompany, announced results of a study showing that ... (lisdexamfetamine dimesylate) CII with the proton... X 2), did not alter the median time it took for m...be reached in the subjects evaluated. In the same...
... ALTO, Calif., May 21 Telik, Inc. (Nasdaq: TELK...mized clinical study of canfosfamide (TELCYTA(R), ...xorubicin (PLD) vs. PLD will be presented at the 4...ical Oncology (ASCO) which will be held from May 2...esentation are as follows: , , , -- Abs...
Other Medicine Technology:New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 2New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 3New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 4New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 5New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 6New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 7New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 8
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: